Table 3.

| compound | R1 | R2 | Anti-TB activity |
Cytotoxicity |
|
|---|---|---|---|---|---|
| H37Rv MIC (µM) | HEK293T CC50 (µM) | HepG2 CC50 (µM) | |||
| 3i | H | H | 0.6 | >40 | 5.8 |
| 20a | H | Me | 0.3 | 17.1 | 16.3 |
| 20b | H | Et | 0.6 | >40 | 5.8 |
| 20c | H | iPr | 0.6 | 16.7 | 12.4 |
| 20d | H | tBu | 1.2 | 13.7 | 6.9 |
| 20e | Me | Me | 0.23 | 14.3 | 8.1 |
| 20f | H | OMe | 0.6 | >40 | >40 |
| 20 g | H | CN | 0.45 | ND | 10.3 |
| 20 h | H | N(Me)2 | 0.31 | >40 | >40 |
| 20i | H | SO2Me | 0.40 | 17.2 | 9.3 |
| 20j | H | COOH | 1.25 | >40 | >40 |
| 20 k | H | CONH2 | 0.17 | >40 | >40 |
| 21a | H | NHCOMe | 0.15 | >40 | >40 |
| 21b | H | NHSO2Me | 0.06 | >40 | >40 |
| 20 l | H | SONH2 | 0.47 | ND | >40 |
| 21c | H | N(Me)SO2Me | 0.31 | ND | 15.3 |
| 21d | H | NHSO2Et | 0.08 | ND | >40 |
| 21e | H | NHSO2iPr | 0.31 | >40 | >40 |
| 21f | H | NHSO2tBu | 2.5 | >40 | >40 |